Page last updated: 2024-08-21

nsc 65346 and cyc 202

nsc 65346 has been researched along with cyc 202 in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cappellini, A; Chiarini, F; Martelli, AM; McCubrey, JA; Ognibene, A	1

Other Studies

1 other study(ies) available for nsc 65346 and cyc 202

Article	Year
The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast Cell cycle (Georgetown, Tex.), 2009, May-01, Volume: 8, Issue:9 Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Nucleosides; Purines; Pyrimidine Nucleosides; RNA, Messenger; Roscovitine	2009

Article

Year

The cyclin-dependent kinase inhibitor roscovitine and the nucleoside analog sangivamycin induce apoptosis in caspase-3 deficient breast cancer cells independent of caspase mediated P-glycoprotein cleavage: implications for therapy of drug resistant breast

Cell cycle (Georgetown, Tex.), 2009, May-01, Volume: 8, Issue:9

Topics: Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Breast Neoplasms; Caspase 3; Cell Line, Tumor; Cyclin-Dependent Kinases; Drug Resistance, Neoplasm; Drug Screening Assays, Antitumor; Gene Expression Regulation, Neoplastic; Humans; Nucleosides; Purines; Pyrimidine Nucleosides; RNA, Messenger; Roscovitine

2009